Cardiovascular Intervention and Therapeutics最新文献

{"title":"Effect of cutting frequency in the jet stream atherectomy system on lumen area acquisition.","authors":"Naoya Kurata, Osamu Iida, Motoki Yasunaga, Taku Toyoshima, Takafumi Masai, Yoshiharu Higuchi","doi":"10.1007/s12928-024-01069-3","DOIUrl":"10.1007/s12928-024-01069-3","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"420-422"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Combined percutaneous pulmonary valve-in-valve and closure of paravalvular leak.","authors":"Ariana Gonzálvez-García, Santiago Jiménez-Valero, Enrique Balbacid-Domingo, César Abelleira-Pardeiro, Federico Gutiérrez-Larraya, Raúl Moreno","doi":"10.1007/s12928-024-01053-x","DOIUrl":"10.1007/s12928-024-01053-x","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"449-450"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cerebral air embolism after accidental air injection into a radial artery sheath.","authors":"Nick Winter, Raoul André Fakkert, Robert Paul Weenink","doi":"10.1007/s12928-025-01097-7","DOIUrl":"10.1007/s12928-025-01097-7","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"429-431"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143063830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter management of residual mitral regurgitation after transcatheter edge-to-edge repair: a systematic review.","authors":"Massimo Baudo, Besart Cuko, Julien Ternacle, Serge Sicouri, Olivier Busuttil, Paolo Denti, Cosmo Godino, Carlo De Vincentiis, Basel Ramlawi, Lionel Leroux, Thomas Modine, Altin Palloshi, Francesco Maisano","doi":"10.1007/s12928-025-01091-z","DOIUrl":"10.1007/s12928-025-01091-z","url":null,"abstract":"<p><strong>Background: </strong>Treatment of residual mitral regurgitation (MR) with different percutaneous devices after transcatheter edge-to-edge repair (TEER) has been reported as an alternative option to reclipping or surgery. This review aims at describing the different transcatheter strategies available and their results when managing residual MR after TEER.</p><p><strong>Methods: </strong>A literature search was undertaken across Pubmed, ScienceDirect, SciELO, DOAJ, and Cochrane library databases, to identify article reporting patients with post-TEER residual MR managed by a transcatheter approach that did not involve only the implantation of new clips.</p><p><strong>Results: </strong>From 439 deduplicated studies, 24 articles ultimately met the inclusion criteria. Fifteen described an occluder device implantation, 12 with an Amplatzer and 3 with a Cardioform. The most feared complications were hemolysis and device embolization. Three cases of transcatheter annuloplasty were reported in patients with residual functional MR. An electrosurgical detachment of the TEER device from the anterior mitral leaflet (ELASTA-Clip) before mitral valve replacement was reported in 6 articles.</p><p><strong>Conclusions: </strong>Transcatheter procedures addressing residual MR after TEER in carefully selected patients are feasible in experienced centers. Outcomes are promising despite some technical issues. Percutaneous strategies and related complications should be anticipated using multimodality imaging.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"255-267"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143000876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of coronary flow restoration just before stent deployment in primary percutaneous coronary intervention.","authors":"Yusuke Watanabe, Kenichi Sakakura, Hiroyuki Jinnouchi, Yousuke Taniguchi, Kei Yamamoto, Masaru Seguchi, Takunori Tsukui, Taku Kasahara, Masashi Hatori, Shun Ishibashi, Hideo Fujita","doi":"10.1007/s12928-025-01088-8","DOIUrl":"10.1007/s12928-025-01088-8","url":null,"abstract":"<p><p>This study aimed to investigate the relationship between the restoration of coronary flow just before stent deployment and the final thrombolysis in myocardial infarction (TIMI) flow grade 3 in patients with ST-segment elevation myocardial infarction (STEMI) whose initial TIMI flow grade ≤ 1. In primary percutaneous coronary intervention (PCI), initial TMI flow grade ≤ 1 is closely associated with suboptimal final TIMI flow grade. We included 466 STEMI patients with initial TIMI flow grade ≤ 1 and divided into a restored flow group or an unrestored flow group according to the TIMI flow grade just before stent deployment. The primary endpoint was the achievement of final TIMI flow grade 3. We compared clinical characteristics between the two groups and performed a multivariate logistic analysis to investigate the association between the coronary flow restoration and the final TIMI flow grade. The prevalence of final TIMI flow grade 3 was significantly higher in the restored flow group than the unrestored flow group. The multivariate logistic regression analysis revealed that the restoration of coronary flow just before stent deployment was significantly associated with final TIMI flow grade 3 (OR 7.771, 95% CI 3.412-17.699, p < 0.001). The restoration of coronary flow just before stent deployment was significantly associated with the achievement of final TIMI flow grade 3 in STEMI patients with initial TIMI flow grade ≤ 1. Interventional cardiologist may pay more attention to the coronary flow restoration just before stent deployment when the initial TIMI flow grade is ≤ 1.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"306-315"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142976815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative safety and efficacy of new-generation single-layer polytetrafluorethylene- versus polyurethane-covered stents in patients with coronary artery perforation for the RECOVER (REsults after percutaneous interventions with COVERed stents) Investigators.","authors":"Felix Voll, Göran Olivecronab, Miroslaw Ferenc, Farrel Hellig, Christian Schlundt, Jochen Wöhrle, Salvatore Cassese, Wolfgang Rottbauer, Adam Witkowski, Erion Xhepa, Wiktor Kuliczkowski, Lisa Strauss, Benedikt Schrage, Michael Joner, Constantin von Zur Mühlen, Stephane Cook, Tomislav Miljak, Holger Eggebrecht, Eric Eeckhout, Karl-Ludwig Laugwitz, Jacques Monsegu, Heribert Schunkert, Dirk Westermann, Adnan Kastrati, Nicolas Dumonteil, Ralf Birkemeyer, Sebastian Kufner","doi":"10.1007/s12928-025-01084-y","DOIUrl":"10.1007/s12928-025-01084-y","url":null,"abstract":"<p><p>New-generation single-layer polytetrafluorethylene (PTFE-) or polyurethane (PU-) covered stent (CS) for the treatment of coronary artery perforation (CAP) during PCI offer high procedural efficacy. To evaluate the comparative long-term safety and efficacy of both devices. This is a multicenter pooled analysis of individual data of patients with CAP undergoing implantation of single-layer PTFE-CS or PU-CS. Procedural endpoint was strategy success defined as successful placement of CS and sealing of perforation without surgical conversion. Clinical endpoints were mortality, myocardial infarction (MI), target vessel revascularization (TVR) and definite or probable stent thrombosis (def/prob ST) at 12 months. Seventy patients with CAP underwent implantation of two hundred eight CS, ninety-two PTFE-CS, and one hundred sixteen PU-CS. More than 1 stent was implanted in 13 patients (17.1%) in PTFE-CS group and 19 patients (20.2%) in PU-CS group, P = 0.80. Strategy success was high (96.1% versus 92.5%., P = 0.62). At 12 months, 71 patients (93.2%) in PTFE-CS group versus 79 patients (81%) in the PU-CS were alive, P = 0.05; TVR occurred in 14 patients (28.4%) in PTFE-CS group and 12 patients (17.9%) in PU-CS group, P= 0.54; MI in 1 patient (1.3%) in PTFE-CS group and 1 patients (1.1%) in PU-CS group, P = 0.86. Rates of def/prob ST were comparable 1.3% in PTFE-CS versus 3.1% in PU-CS P = 0.95. A strategy of implantation of a new-generation single-layer PTFE- or PU-CS for the treatment of coronary artery perforation showed high success rates. Both new-generation CS showed favorable and similar clinical safety, in particular with regard to thrombotic events.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"296-305"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143363739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter aortic valve implantation in elderly patients with severe aortic stenosis and rheumatic phenotype.","authors":"Ahmed Abdelrahman Elkaialy, Nabil Farag, Ahmad Elsayed Mostafa, Mahmoud Baraka, Diaa Kamal","doi":"10.1007/s12928-025-01113-w","DOIUrl":"https://doi.org/10.1007/s12928-025-01113-w","url":null,"abstract":"<p><p>Significant fibrosis is characteristic of rheumatic aortic valve disease that affects anchoring and deployment of the trans-catheter heart valve. Our goal was to determine whether trans-catheter aortic valve implantation (TAVI) is an effective treatment option for severe aortic stenosis patients with rheumatic valvular disease. This study is a prospective cohort study that includes a total of 54 rheumatic severe aortic stenosis patients who were referred for TAVI. The age ranged from 65.00 to 83.00 years (mean age 72.75 ± 5.86 years). Notably, 63% of the patients had undergone preimplantation balloon dilatation. The outcomes included total new conduction disturbances (transient and permanent defects of atrio-ventricular block and left bundle branch block) in 31.4% of the patients, permanent pacemaker implantation in 3.7%, and valve embolization in 1.85%, and no patients had moderate to severe para-valvular leak. All-cause death within a 6-month follow-up was 3.7%. This cohort was then compared to a propensity score matched group of degenerative calcific severe aortic stenosis of 54 cases revealing comparable post-procedural results. Compared with the outcomes of TAVI in patients with degenerative aortic stenosis, TAVI represents a viable and durable option for rheumatic severe aortic stenosis patients.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A case of hemolytic anemia after implantation of Sapien3 Ultra RESILIA requiring post-dilation.","authors":"Atsushi Iizuka, Harutoshi Tamura, Shunsuke Edamura, Satoshi Nishiyama, Tetsu Watanabe, Masafumi Watanabe","doi":"10.1007/s12928-025-01120-x","DOIUrl":"https://doi.org/10.1007/s12928-025-01120-x","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic value of HELT-E₂S₂ score among patients undergoing percutaneous coronary intervention: sub-analysis of the SHINANO 5-year registry.","authors":"Daisuke Sunohara, Tatsuya Saigusa, Yasushi Ueki, Masatoshi Minamisawa, Tadashi Itagaki, Yoshiteru Okina, Kiu Tanaka, Hidetomo Nomi, Tamon Kato, Soichiro Ebisawa, Takashi Miura, Koichiro Kuwahara","doi":"10.1007/s12928-025-01123-8","DOIUrl":"https://doi.org/10.1007/s12928-025-01123-8","url":null,"abstract":"<p><p>The HELT-E₂S₂ score has recently been proposed as a new risk stratification tool for ischemic stroke in Japanese patients with atrial fibrillation (AF). We aimed to evaluate the prognostic value of HELT-E₂S₂ score for cardiovascular events among patients undergoing percutaneous coronary intervention (PCI). Between August 2012 and July 2013, patients undergoing PCI enrolled in the SHINANO 5-year registry, a prospective, observational multicenter registry, were analyzed for the current study. Primary endpoint was major adverse cardiovascular events (MACE), a composite of all-cause death, myocardial infarction, and ischemic stroke at 5 years. Key secondary endpoint was bleeding events at 5 years. A total of 1608 patients were divided into the low HELT-E₂S₂ score group (< 2, n = 915) and high HELT-E₂S₂ score group (≥ 2, n = 693). Major criteria of the HELT-E₂S₂ score were hypertension (74.7%), elderly age 75-84 years (31.3%), and AF (11.1%). Kaplan-Meier analysis revealed that the high HELT-E₂S₂ score group had a significantly higher incidence of MACE (33.4% vs. 14.8%, P < 0.001) and bleeding events (12.7% vs. 5.3%, P < 0.001) compared with the low HELT-E₂S₂ score group. Multivariable analysis demonstrated that the HELT-E₂S₂ score remained significantly associated with MACE (hazard ratio: 1.73, 95% confidence interval: 1.11-2.69; P = 0.015). The HELT-E₂S₂ score appears a useful tool for predicting future cardiovascular events in CAD patients undergoing PCI.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143742521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"When brain and heart collide: a deeper dive into treatment pathways of stroke complicating TAVI.","authors":"Mark Kheifets, Boris Kruchin, Guy Witberg, Tsahi T Lerman, Rani Barnea, Michael Findler, Ran Brauner, Leor Perl, Pablo Codner, Yeela Talmor-Barkan, Guy Rephaeli, Eitan Auriel, Ran Kornowski, Amos Levi","doi":"10.1007/s12928-025-01121-w","DOIUrl":"https://doi.org/10.1007/s12928-025-01121-w","url":null,"abstract":"<p><p>Periprocedural ischemic stroke remains a major concern of transcatheter aortic valve implantation (TAVI). The aims of this study were to describe the incidence, characteristic, and outcomes of patients presenting with acute ischemic stroke complicating TAVI (AISCT), and to compare conservative management (CM) vs. neurointervention (NI), in eligible patients. We analyzed consecutive TAVI procedures performed in the Rabin Medical Center between 2008 and 2021. The patients with and without AISCT were compared. Outcomes of NI following AISCT were compared to CM. The primary outcomes were mortality at 1 and 3 years and neurologic disability status at 3 months. Of 1515 eligible patients who underwent TAVI between 2008 and 2021, 38 (2.5%) had AISCT within 30 days. All-cause mortality was significantly higher in the AISCT group in 30 days (13.9% vs. 2.4%, p < 0.01), 1 year (27.8% vs. 8.1%, p < 0.01), and 3 years (49.0% vs. 26.8%, p < 0.01), as compared to the AISCT negative group. Out of the 38 patients who suffered AISCT between 2008 and 2021, 7 underwent NI. The majority of AISCT were observed within the first 24-h following TAVI (p < 0.01). All-cause mortality following moderate/severe stroke was significantly higher (p = 0.037) compared to mild stroke. As compared to the CM, NI was not found to reduce mortality. However, patients with moderate severity stroke who underwent NI enjoyed a higher rate of disability free survival at 3 months (100% vs. 40%, p = 0.044), compared to patients treated conservatively. NI, as compared to CM, may improve disability status in eligible patients with moderate stroke.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143742522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}